ICCMIcecure Medical Ltd
ICCM
Icecure Medical Ltd2,838
Mkt Cap
$47.4MVolume
271,075.0052W High
$1.5352W Low
$0.5401PE Ratio
-2.70ICCM Fundamentals
Price
$0.69Prev Close
$0.6889Open
$0.69550D MA
$0.6264Beta
0.66Avg. Volume
174,692.29EPS (Annual)
-$0.2954P/B
5.11Rev/Employee
$45,708.33$48.86
U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense Cryoablation in the Local Treatment of Low-Risk Breast Cancer
U.S. FDA Approves IceCure's Post-Marketing 'ChoICE' Study for ProSense Cryoablation in the Local Treatment of Low-Risk Breast Cancer U.S. FDA Approves IceCure's Post-Marketing 'ChoICE' Study for...
PR Newswire·4d ago
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026
IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 IceCure Medical to Report 2025 Full Year Financial and Operating Results on March 17, 2026 PR Newswire...
PR Newswire·5d ago
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer
American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends...
PR Newswire·6d ago
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas IceCure Medical Reports Independent Study...
PR Newswire·13d ago
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026
IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 IceCure Medical Successfully Completes...
PR Newswire·20d ago
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation
IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation IceCure Announces Thomas Hospital of Infirmary Health...
PR Newswire·24d ago
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense
IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation...
PR Newswire·1mo ago
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved
IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones...
PR Newswire·1mo ago
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense Sales
IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense Sales IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025...
PR Newswire·2mo ago
IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense Cryoablation for Low-Risk Breast Cancer
IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense Cryoablation for Low-Risk Breast Cancer IceCure Expected to Report Record Fourth...
PR Newswire·3mo ago
<
1
2
...
>